Hypothyroidism: Difference between revisions

Jump to navigation Jump to search
Line 147: Line 147:
==Differential diagnosis==
==Differential diagnosis==
{| align="center" style="border: 0px; font-size: 90%; margin: 3px;"
{| align="center" style="border: 0px; font-size: 90%; margin: 3px;"
!
! rowspan="2" align="center" style="background:#DCDCDC;" |Disease
! rowspan="2" align="center" style="background:#DCDCDC;" |Disease
! colspan="5" align="center" style="background:#DCDCDC;" |History and symptoms
! colspan="5" align="center" style="background:#DCDCDC;" |History and symptoms
Line 152: Line 153:
! rowspan="2" align="center" style="background:#DCDCDC;" |Additional findings
! rowspan="2" align="center" style="background:#DCDCDC;" |Additional findings
|-
|-
!
! align="center" style="background:#DCDCDC;" |Fever
! align="center" style="background:#DCDCDC;" |Fever
! align="center" style="background:#DCDCDC;" |Goiter
! align="center" style="background:#DCDCDC;" |Goiter
Line 166: Line 168:
! align="center" style="background:#DCDCDC;" |Serum [[glucagon]]
! align="center" style="background:#DCDCDC;" |Serum [[glucagon]]
|-
|-
|
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Primary hypothyroidism
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Primary hypothyroidism
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 183: Line 186:
([[GAD65|Anti GAD-65]] and anti insulin anti bodies)
([[GAD65|Anti GAD-65]] and anti insulin anti bodies)
|-
|-
|
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Transient hypothyroidism
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Transient hypothyroidism
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 199: Line 203:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans]]
|-
|-
|
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Subclinical hypothyroidism
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Subclinical hypothyroidism
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 215: Line 220:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
|-
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |
| rowspan="2" |Central Hypothyroidism
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Pituitary
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 231: Line 237:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
|-
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Hypothalamus
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 247: Line 253:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
|-
|-
|
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Transient [[hyperglycemia]]
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Transient [[hyperglycemia]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 263: Line 270:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |In hospitalized patients especially in [[ICU]] and [[CCU]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |In hospitalized patients especially in [[ICU]] and [[CCU]]
|-
|-
|
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Steroid]] therapy
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Steroid]] therapy
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 279: Line 287:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans|Acanthosis nigricans,]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans|Acanthosis nigricans,]]
|-
|-
|
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[RTA|RTA 1]]
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[RTA|RTA 1]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 295: Line 304:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Hypokalemia]], [[nephrolithiasis]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Hypokalemia]], [[nephrolithiasis]]
|-
|-
|
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Glucagonoma]]
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Glucagonoma]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 311: Line 321:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Necrolytic migratory erythema]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Necrolytic migratory erythema]]
|-
|-
|
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Cushing's syndrome|Cushing syndrome]]
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Cushing's syndrome|Cushing syndrome]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -

Revision as of 13:28, 11 July 2017


For patient information click here

Hypothyroidism Main page

Patient Information

Overview

Classification

Primary hypothyroidism
Hashimoto's thyroiditis
Secondary hypothyroidism
Tertiary hypothyroidism

Differentiating different causes of hypothyroidism

Screening

Diagnosis

History and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Synonyms and keywords: Myxedema; myxoedema; thyroid activity decreased; hypothyroid

Overview

Classification

Origin of the defect Causes
Endagenous causes Exagenous causes
Thyroid Pituirtary Hypothalamus Surgery or radiation Other causes
Primary hypothyroidism + - -
  • Congenital hypothyroidism
  • Autoimmune (Hashimoto's) thyroiditis
  • Thyroidectomy
  • Radioiodine therapy
  • Iodine deficeincy
  • Drug induced thyroiditis
    • Amiodarone
    • Lithium
    • Thionamide
    • Iodine
    • Iterferon
    • Sunitinib
    • Rifampicin
    • Thalidomide
Transient hypothyroidism + + -
  • Subacute (de Quervain’s) thyroiditis
  • Postpartum thyroiditis
Secondary hypothyroidism - + -
  • Pituitary mass lesions, especially pituitary adenomas
  • Brain cysts and abscesses
  • meningiomas
  • dysgerminomas
  • metastatic tumors
  • craniopharyngiomas
  • pituitary apoplexy
  • Sheehan syndrome (postpartum pituitary necrosis)
  • Idiopathic isolated TSH deficiency
  • surgery of pituitary adenomas
  • radiation therapy
    • pituitary adenomas
    • other mass lesions near pituitary gland
  • head trauma with injury of the stalk
Tertiary hypothyroidism - - +
  • hemochromatosis
  • histiocytosis
  • autoimmune lymphocytic hypophysitis
  • Developmental abnormalities
  • internal carotid aneurysms
  • Other central nervous system (CNS) tumors
  • Idiopathic isolated TRH deficiency
  • Radiation in high doses to the
    • brain
    • infratemporal
    • nasopharyngeal
    • oropharyngeal
  • Infections
    • tuberculosis
    • syphilis
    • toxoplasmosis
  • sarcoidosis

hei

  • Primary hypothyroidism
    • Congenital hypothyroidism
    • Autoimmune (Hashimoto's) thyroiditis
    • Iodine deficeincy
    • Drug induced thyroiditis
      • Amiodarone
      • Lithium
      • Thionamide
      • Iodine
      • Iterferon
      • Sunitinib
      • Rifampicin
      • Thalidomide
    • Thyroidectomy
    • Radioiodine therapy
  • Transient hypothyroidism
    • Subacute (de Quervain’s) thyroiditis
    • Postpartum thyroiditis
  • Secondary hypothyroidism (due to decreased levels of TSH)
    • Pituitary mass lesions, especially pituitary adenomas
    • cysts and abscesses
    • meningiomas
    • dysgerminomas
    • metastatic tumors
    • craniopharyngiomas
    • surgery or radiation therapy for pituitary adenomas or other mass lesions near pituitary gland
    • head trauma with injury of the stalk
    • pituitary apoplexy
    • Sheehan syndrome (postpartum pituitary necrosis)
    • Idiopathic isolated TSH deficiency
  • Tertiary hypothyroidism
    • Infiltrative disorders affecting the pituitary or the hypothalamus include hemochromatosis, and histiocytosis
    • autoimmune lymphocytic hypophysitis
    • Developmental abnormalities
    • internal carotid aneurysms
    • Other central nervous system (CNS) tumors
    • Idiopathic isolated TRH deficiency

Differential diagnosis

Disease History and symptoms Laboratory findings Additional findings
Fever Goiter Serum glucose Urinary Glucose Urine PH Serum Sodium Urinary Glucose 24 hrs cortisol level C-peptide level Serum glucagon
Primary hypothyroidism + + + + - Normal Normal N/ Normal Normal Auto antibodies present

(Anti GAD-65 and anti insulin anti bodies)

Transient hypothyroidism + + + + - Normal Normal Normal Normal Acanthosis nigricans
Subclinical hypothyroidism + + + - + Normal Normal Normal Normal N -
Central Hypothyroidism Pituitary + + - - - Normal Normal Normal Normal Normal Normal Normal -
Hypothalamus + + - - - Normal Normal Normal Normal Normal Normal Normal -
Transient hyperglycemia - - - - - Normal Normal Normal Normal N/ In hospitalized patients especially in ICU and CCU
Steroid therapy + - - - + Normal Normal N/ N/ Acanthosis nigricans,
RTA 1 - - - + - Normal Normal Normal Normal Normal Normal Hypokalemia, nephrolithiasis
Glucagonoma - - - - - Normal Normal Normal - Normal Normal Necrolytic migratory erythema
Cushing syndrome - - - - + - Normal N/ Normal Normal Moon face, obesity, buffalo hump, easy bruisibility

General feature

Symptoms

Constituitional Local Reproductive Neuropsysiological Others Physical exam
cold intolerance

puffiness

decreased sweating

coarse skin

hypothermia

Fever if accompanied by thyroiditis

weight gain

coarse, brittle, straw like hair with hair loss

obstructive sleep apnea (secondary to macroglossia) Females can present with galactorrhea and menstrual disturbances depression paresthesia and nerve entrapment syndromes decreased systolic blood pressure

increased diastolic blood pressure

bradycardia

pericardial effusion

abdominal distension

ascites (uncommon)

non-pitting edema (myxedema)

pitting edema of lower extremities

hyporeflexia with delayed relaxation

ataxia

fullness and pain in the throat and neck infertility emotional lability constipation
  • hoarseness
  • sore throat
blurred vision macroglossia
goiter Attention deficit periorbital puffiness
slowed speech and movements
  • Metabolic abnormalities associated with hypothyroidism include:
    • anemia,
    • dilutional hyponatremia,
    • hyperlipidemia,
    • reversible increase in creatinine

Complications

Myxedema coma

Rare, severe form of hypothyroidism, a life-threatening condition

  • Altered mental status,
  • hypothermia,
  • bradycardia,
  • hypercarbia, and
  • hyponatremia.
  • Cardiomegaly,
  • pericardial effusion,
  • cardiogenic shock, and
  • ascites
  • commonly occurs in individuals with undiagnosed or untreated hypothyroidism who is subjected to an external stress, such as low temperature, infection, or medical intervention (e.g., surgery or hypnotic drugs)

Screening

Diagnosis

Treatment

Prevention